Supplement to Prebiotics Intervention to Reduce Alzheimer's Disease Risk via Brain-Gut Axis in an APOE4 Mouse Model
Description: The proposed research is relevant to public health because we will use multi-omics approaches, neuroimaging, and molecular assays to assess efficacy of prebiotic inulin diet for protecting brain vascular and metabolic functions via gut microbiome modification in mice that carry APOE4 genes, the strongest genetic risk factor for Alzheimer’s disease (AD). Because multi- omics and neuroimaging methods are readily to be used in humans and inulin diet is commercially available, the findings from the study will provide valuable information, and may pave a way, for future dietary clinical trials to reduce AD risk for pre-symptomatic APOE4 carriers.
Funder: National Institute on Aging
Funding type: research
Funder scheme: RF1
Start date: 2019-05-01
End date: 2024-08-31
Investigator: AI-LING LIN (lead)
Institutions: University of Missouri, UNIVERSITY OF MISSOURI-COLUMBIA
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 29
Funder award ID: RF1AG062480
OpenAlex ID: G1641016854
